Published 19 days ago

US FDA approves Amgen drug for small cell lung cancer

Summary by Devdiscourse

US FDA approves Amgen drug for small cell lung cancer The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung cancer that has worsened despite chemotherapy.The drug, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific antibodies designed to attach to a cancer cell and an immune cell, …

0 Articles

All

Left

Center

Right

Star Advertiser

FDA approves Amgen drug for small cell lung cancer | Honolulu Star-Advertiser

The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen’s tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung cancer that has worsened despite chemotherapy.

18 days ago·Honolulu, United States

Read Full Article

The Globe & Mail

U.S. FDA approves Amgen drug for small cell lung cancer

U.S. Food and Drug Administration fast-tracks approval for Amgen drug shown to shrink lung tumours

18 days ago·Canada

Read Full Article

Devdiscourse

US FDA approves Amgen drug for small cell lung cancer

18 days ago

Read Full Article

Medscape

FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung Cancer

Continued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit. Medscape Medical News

19 days ago·United States

Read Full Article

MarketWatch

Amgen gets FDA approval for small-cell lung-cancer treatment

Amgen on Thursday received approval from U.S. regulators for its drug to treat a form of late-stage lung-cancer.

18 days ago·United States

Read Full Article

New Hampshire Union Leader

FDA approves Amgen drug for small cell lung cancer

The Food and Drug Administration on Thursday granted accelerated approval to Amgen’s tarlatamab, a targeted immunotherapy for treating adults with advanced small cell lung cancer that has worsened despite chemotherapy.

18 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.